![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- ACOG Practice Bulletin No. 196: thromboembolism in pregnancy. 2018. Obstetrics and Gynecology 132:e1–e17.
- Agaba P, Kildow BJ, Dhotar H, Seyler TM, Bolognesi M. 2017. Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors. Journal of Orthopaedics 14:537–543.
- Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. 2012. VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e691S–e736S.
- Blondon M, Casini A, Hoppe KK, Boehlen F, Righini M, Smith NL. 2016. Risks of venous thromboembolism after cesarean sections: a meta-analysis. Chest 150:572–596.
- Greer IA, Nelson-Piercy C. 2005. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood 106:401–407.
- Kobayashi T, Nakabayashi M, Ishikawa M, Adachi T, Kobashi G, Maeda M, et al. 2008. Pulmonary thromboembolism in obstetrics and gynecology increased by 6.5-fold over the past decade in Japan. Circulation Journal 72:753–756.
- Moen V, Dahlgren N, Irestedt L. 2004. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 101:950–959.
- Mukai M, Kashiwagi Y, Itoh H, Furuta N, Murakami H, Tamura N, et al. 2016. Comparison between enoxaparin sodium and unfractionated heparin administered within 24 hours of cesarean section. Hypertension Research in Pregnancy 4:16–23.
- Newcombe RG, Altman DG. 2000. Proportions and their differences. In: Altman D, Machin D, Bryant T, Gardner V, editors. Statistics with confidence: confidence intervals and statistical guidelines. 2nd ed. London: Blackwell BMJ Books. p. 45–56.
- Royal College of Obstetricians and Gynaecologists. 2015. Thromboembolic disease in pregnancy and the puerperium: acute management. Green-top Guideline No. 37b. London: Royal College of Obstetricians and Gynaecologists.
- Shiga T, Takahashi Y, Iwagaki S, Chiaki R, Asai K, Matsui M, et al. 2016. Safety and availability of low-molecular-weight heparin within 24 hours after Cesarean section. Tokai Journal of Obstetrics and Gynecology 52:111–117.
- Sakon M, Kobayashi T, Shimazui T. 2010. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thrombosis Research 125:e65–e70.
- Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M, et al. 1995. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. New England Journal of Medicine 332:1330–1335.
- Watanabe T, Matsubara S, Usui R, Izumi A, Kuwata T, Suzuki M. 2011. No increase in hemorrhagic complications with thromboprophylaxis using low-molecular-weight heparin soon after cesarean section. Journal of Obstetrics and Gynaecology Research 37:1208–1211.